Pediatric endocrinology

Reduction in Pappalysin-2 Levels and Lower IGF-I Bioavailability in Female Adolescents With Anorexia Nervosa

J Clin Endocrinol MetabPublished Case-control study

Authors' conclusion

The reduction of PAPP-A2 in patients with AN may be involved in a decline in IGFBP cleavage, which could underlie the decrease in IGF-I bioavailability that is influenced by nutritional status and amenorrhea.

Study context

Population
Female adolescents with anorexia nervosa (AN) at diagnosis
Participants
68 vs 62
Comparison
Female adolescents with AN vs matched controls
  • ANn = 68
  • Controlsn = 62reference
Outcome
Serum levels of PAPP-As and STCs in relationship with classical IGF axis parameters
Follow-up
At diagnosis
Methodological detailssex- and age-matched controls
  • Sex- and age-matched controls

Main finding

As reported in the abstract

IGF axis parameters, PAPP-As and STCs
  • AN had lower total and free IGF-I, total IGFBP-3, acid-labile subunit (ALS), insulin, PAPP-A2, stanniocalcins (STC-1) and STC-2 vs controls
  • AN had higher IGF-II and IGFBP-2
  • AN had decreased free/total IGF-I ratio and increased intact/total IGFBP-3 and −4 ratios

Observational data: associations, not effects.

Further findings

Associations with body mass index (BMI), weight loss and bone mineral density (BMD)

BMI directly related to total IGF-I and intact IGFBP-3, inversely to IGFBP-2 and intact IGFBP-4
Weight loss directly correlated with intact IGFBP-4, negatively with intact IGFBP-3, ALS, STC-2 and PAPP-A2
BMD directly related to intact IGFBP-3, inversely to intact IGFBP-4 and PAPP-A2

Secondary amenorrhea

Amenorrhea associated with lower total IGF-I and IGFBP-3 than menses

Original publication

Reduction in Pappalysin-2 Levels and Lower IGF-I Bioavailability in Female Adolescents With Anorexia Nervosa. J Clin Endocrinol Metab. Published 8 December 2023. doi:10.1210/clinem/dgad713

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.